
Antiphospholipid Syndrome in Systemic Autoimmune Diseases: Volume 12
Elsevier (Verlag)
Erschienen am 28. April 2009
Buch
Hardcover
266 Seiten
978-0-444-53169-8 (ISBN)
Artikel ist vergriffen; siehe Neuauflage
Beschreibung
Antiphospholipid syndrome is an autoimmune disease that causes abnormal blood clots. It is now recognized as a major cause of common conditions, including stroke, heart attack, miscarriage, epilepsy and memory loss and as such is gaining recognition in all branches of medicine, from obstetrics to cardiology, from psychiatry to orthopedics.This book provides an overview of our current understanding of this major disease. It includes the latest information on the new pathogenetic mechanisms involved as well as clinical manifestations in both "the thrombotic? and "non-thrombotic? manifestations of this important disease.
Rezensionen / Stimmen
Immunologists, rheumatologists, obstetricians, hematologists, fellows, medical student and those working in internal medicine and general medicine. As well as medical/scientific management and pharmaceutical companies.Weitere Details
Reihe
Sprache
Englisch
Verlagsort
Oxford
Großbritannien
Verlagsgruppe
Elsevier Science & Technology
Zielgruppe
Für Beruf und Forschung
Immunologists, rheumatologists, obstetricians, haematologists, fellows, medical student and those working in internal medicine and general medicine. As well as medical/scientific management and pharmaceutical companies.
Maße
Höhe: 262 mm
Breite: 192 mm
Gewicht
850 gr
ISBN-13
978-0-444-53169-8 (9780444531698)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Klassifikation
Weitere Ausgaben
Nachauflagen

R. Cervera | Joan Carles Reverter | Munther Khamashta
Antiphospholipid Syndrome in Systemic Autoimmune Diseases: Volume 12
Buch
06/2016
2. Auflage
Elsevier
156,99 €
Versand in 15-20 Tagen
Personen
Munther Khamashta is Professor/Consultant Physician and Director of The Graham Hughes Lupus Research Laboratory at St Thomas' Hospital, London, and runs a large lupus pregnancy clinic. He studied medicine in Barcelona and internal medicine in Madrid, Spain, where he developed an interest in connective tissue diseases and received his PhD. He was awarded the MRCP in 1999 and FRCP in 2002. He joined the Lupus Unit in London 25 years ago and has been instrumental in developing it into an internationally recognised tertiary centre receiving referrals from all over the UK, see https://kclpure.kcl.ac.uk/portal/en/persons/munther-khamashta(e30b3284-8df1-4cc2-9856-9bca61db843e)/biography.html
Herausgeber*in
Department of Autoimmune Diseases, Hospital Clinic, Barcelona, Spain
Servei d'Hemoterapia i Hemostasia, Hospital Clinic, Barcelona, Spain
Professor/Consultant Physician and Director of The Graham Hughes Lupus Research Laboratory at St Thomas' Hospital, London, and runs a large lupus pregnancy clinic.
Inhalt
Classification and Epidemiology of the Antiphospholipid Syndrome;
Laboratory Heterogeneity of the Antiphospholipid Antibodies:
Pathogenesis of the Antiphospholipid Syndrome;
Immunogenetics of the Antiphospholipid Syndrome;
Systemic Manifestations of the Antiphospholipid Syndrome;
Obstetric Manifestations of the Antiphospholipid Syndrome;
Antiphospholipid Antibodies and Infections and Drugs;
Antiphospholipid Antibodies and Malignancies;
Antiphospholipid Antibodies and Vascular Disorders (Atheromatosis and Vasculitis);
Treatment of the Antiphospholipid Syndrome;
Difficult situations in the Antiphospholipid Syndrome;
Laboratory Heterogeneity of the Antiphospholipid Antibodies:
Pathogenesis of the Antiphospholipid Syndrome;
Immunogenetics of the Antiphospholipid Syndrome;
Systemic Manifestations of the Antiphospholipid Syndrome;
Obstetric Manifestations of the Antiphospholipid Syndrome;
Antiphospholipid Antibodies and Infections and Drugs;
Antiphospholipid Antibodies and Malignancies;
Antiphospholipid Antibodies and Vascular Disorders (Atheromatosis and Vasculitis);
Treatment of the Antiphospholipid Syndrome;
Difficult situations in the Antiphospholipid Syndrome;